S&P 500   3,134.34 (-2.84%)
DOW   27,135.72 (-2.95%)
QQQ   215.94 (-2.46%)
AAPL   290.99 (-2.41%)
FB   197.71 (-1.50%)
MSFT   168.86 (-1.19%)
GOOGL   1,393.54 (-1.85%)
AMZN   1,965.68 (-2.17%)
CGC   19.55 (-3.69%)
NVDA   262.43 (-3.97%)
BABA   205.13 (-0.50%)
MU   51.95 (-5.56%)
GE   11.24 (-5.23%)
TSLA   798.33 (-4.25%)
AMD   47.38 (-3.54%)
T   37.52 (-1.39%)
ACB   1.50 (-3.23%)
F   7.26 (-4.22%)
NFLX   360.07 (-2.34%)
BAC   31.13 (-4.89%)
DIS   128.65 (-3.28%)
GILD   69.51 (-4.65%)
S&P 500   3,134.34 (-2.84%)
DOW   27,135.72 (-2.95%)
QQQ   215.94 (-2.46%)
AAPL   290.99 (-2.41%)
FB   197.71 (-1.50%)
MSFT   168.86 (-1.19%)
GOOGL   1,393.54 (-1.85%)
AMZN   1,965.68 (-2.17%)
CGC   19.55 (-3.69%)
NVDA   262.43 (-3.97%)
BABA   205.13 (-0.50%)
MU   51.95 (-5.56%)
GE   11.24 (-5.23%)
TSLA   798.33 (-4.25%)
AMD   47.38 (-3.54%)
T   37.52 (-1.39%)
ACB   1.50 (-3.23%)
F   7.26 (-4.22%)
NFLX   360.07 (-2.34%)
BAC   31.13 (-4.89%)
DIS   128.65 (-3.28%)
GILD   69.51 (-4.65%)
S&P 500   3,134.34 (-2.84%)
DOW   27,135.72 (-2.95%)
QQQ   215.94 (-2.46%)
AAPL   290.99 (-2.41%)
FB   197.71 (-1.50%)
MSFT   168.86 (-1.19%)
GOOGL   1,393.54 (-1.85%)
AMZN   1,965.68 (-2.17%)
CGC   19.55 (-3.69%)
NVDA   262.43 (-3.97%)
BABA   205.13 (-0.50%)
MU   51.95 (-5.56%)
GE   11.24 (-5.23%)
TSLA   798.33 (-4.25%)
AMD   47.38 (-3.54%)
T   37.52 (-1.39%)
ACB   1.50 (-3.23%)
F   7.26 (-4.22%)
NFLX   360.07 (-2.34%)
BAC   31.13 (-4.89%)
DIS   128.65 (-3.28%)
GILD   69.51 (-4.65%)
S&P 500   3,134.34 (-2.84%)
DOW   27,135.72 (-2.95%)
QQQ   215.94 (-2.46%)
AAPL   290.99 (-2.41%)
FB   197.71 (-1.50%)
MSFT   168.86 (-1.19%)
GOOGL   1,393.54 (-1.85%)
AMZN   1,965.68 (-2.17%)
CGC   19.55 (-3.69%)
NVDA   262.43 (-3.97%)
BABA   205.13 (-0.50%)
MU   51.95 (-5.56%)
GE   11.24 (-5.23%)
TSLA   798.33 (-4.25%)
AMD   47.38 (-3.54%)
T   37.52 (-1.39%)
ACB   1.50 (-3.23%)
F   7.26 (-4.22%)
NFLX   360.07 (-2.34%)
BAC   31.13 (-4.89%)
DIS   128.65 (-3.28%)
GILD   69.51 (-4.65%)
Log in

Otonomy News Headlines (NASDAQ:OTIC)

$3.32
-0.12 (-3.49 %)
(As of 02/25/2020 02:28 PM ET)
Today's Range
$3.26
Now: $3.32
$3.51
50-Day Range
$3.20
MA: $3.51
$4.06
52-Week Range
$2.08
Now: $3.32
$4.18
Volume58,156 shs
Average Volume207,972 shs
Market Capitalization$102.09 million
P/E RatioN/A
Dividend YieldN/A
Beta2.76

Headlines

Otonomy (NASDAQ OTIC) News Headlines

Source:
DateHeadline
Otonomy to Present at Two Upcoming Investor Conferences - StreetInsider.comOtonomy to Present at Two Upcoming Investor Conferences - StreetInsider.com
www.streetinsider.com - February 25 at 8:06 AM
Otonomy to Present at Two Upcoming Investor Conferences - Yahoo FinanceOtonomy to Present at Two Upcoming Investor Conferences - Yahoo Finance
finance.yahoo.com - February 24 at 7:58 AM
Otonomy to Present at Two Upcoming Investor ConferencesOtonomy to Present at Two Upcoming Investor Conferences
finance.yahoo.com - February 24 at 7:58 AM
Do Options Traders Know Something About Otonomy (OTIC) Stock We Dont? - NasdaqDo Options Traders Know Something About Otonomy (OTIC) Stock We Don't? - Nasdaq
www.nasdaq.com - February 22 at 9:11 AM
Do Options Traders Know Something About Otonomy (OTIC) Stock We Dont? - Yahoo FinanceDo Options Traders Know Something About Otonomy (OTIC) Stock We Don't? - Yahoo Finance
finance.yahoo.com - February 21 at 12:15 PM
Do Options Traders Know Something About Otonomy (OTIC) Stock We Don't?Do Options Traders Know Something About Otonomy (OTIC) Stock We Don't?
finance.yahoo.com - February 21 at 12:15 PM
Otonomy (OTIC) Set to Announce Earnings on ThursdayOtonomy (OTIC) Set to Announce Earnings on Thursday
www.americanbankingnews.com - February 21 at 11:30 AM
Otonomy to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Corporate Update - Yahoo FinanceOtonomy to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Corporate Update - Yahoo Finance
finance.yahoo.com - February 20 at 3:06 PM
Otonomy to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Corporate UpdateOtonomy to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Corporate Update
finance.yahoo.com - February 20 at 7:57 AM
AGTC Announces Completion of Enrollment in the Two Highest Dose Groups of its Ongoing Phase 1/2 Clinical Trial in Patients with X-Linked Retinitis Pigmentosa - Yahoo FinanceAGTC Announces Completion of Enrollment in the Two Highest Dose Groups of its Ongoing Phase 1/2 Clinical Trial in Patients with X-Linked Retinitis Pigmentosa - Yahoo Finance
finance.yahoo.com - February 19 at 12:37 PM
$110,000.00 in Sales Expected for Otonomy Inc (NASDAQ:OTIC) This Quarter$110,000.00 in Sales Expected for Otonomy Inc (NASDAQ:OTIC) This Quarter
www.americanbankingnews.com - February 16 at 3:02 AM
-$0.47 EPS Expected for Otonomy Inc (NASDAQ:OTIC) This Quarter-$0.47 EPS Expected for Otonomy Inc (NASDAQ:OTIC) This Quarter
www.americanbankingnews.com - February 14 at 6:24 PM
94 Biggest Movers From Yesterday - Benzinga94 Biggest Movers From Yesterday - Benzinga
www.benzinga.com - February 12 at 9:45 AM
Otonomy Inc (NASDAQ:OTIC) Given Consensus Rating of "Buy" by BrokeragesOtonomy Inc (NASDAQ:OTIC) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - February 12 at 9:27 AM
Otonomy Inc (NASDAQ:OTIC) Sees Significant Growth in Short InterestOtonomy Inc (NASDAQ:OTIC) Sees Significant Growth in Short Interest
www.americanbankingnews.com - February 12 at 12:12 AM
Equities Analysts Offer Predictions for Otonomy Incs FY2024 Earnings (NASDAQ:OTIC)Equities Analysts Offer Predictions for Otonomy Inc's FY2024 Earnings (NASDAQ:OTIC)
www.americanbankingnews.com - February 10 at 4:42 AM
AGTC Announces Proposed Public Offering of Common Stock - Yahoo FinanceAGTC Announces Proposed Public Offering of Common Stock - Yahoo Finance
finance.yahoo.com - February 5 at 10:24 PM
Otonomy Presents Preclinical Results for GJB2 Gene Therapy Collaboration and Cisplatin Otoprotection Program - Yahoo FinanceOtonomy Presents Preclinical Results for GJB2 Gene Therapy Collaboration and Cisplatin Otoprotection Program - Yahoo Finance
finance.yahoo.com - January 28 at 8:54 AM
Otonomy (OTIC) Highlights Preclinical Results for GJB2 Gene Therapy Collaboration and Cisplatin Otoprotection Program - StreetInsider.comOtonomy (OTIC) Highlights Preclinical Results for GJB2 Gene Therapy Collaboration and Cisplatin Otoprotection Program - StreetInsider.com
www.streetinsider.com - January 28 at 8:54 AM
Otonomy Presents Preclinical Results for GJB2 Gene Therapy Collaboration and Cisplatin Otoprotection ProgramOtonomy Presents Preclinical Results for GJB2 Gene Therapy Collaboration and Cisplatin Otoprotection Program
finance.yahoo.com - January 28 at 8:54 AM
Otonomy Announces Multiple Presentations at Association for Research in Otolaryngology Annual Meeting - Yahoo FinanceOtonomy Announces Multiple Presentations at Association for Research in Otolaryngology Annual Meeting - Yahoo Finance
finance.yahoo.com - January 23 at 8:11 AM
AGTC to Host Conference Call and Webcast on January 23 at 8:00 am ET to Discuss Achromatopsia Interim Six-Month Data from the Dose Escalation Cohorts of its Ongoing CNGB3 and CNGA3 Phase 1/2 Clinical Trials - Yahoo FinanceAGTC to Host Conference Call and Webcast on January 23 at 8:00 am ET to Discuss Achromatopsia Interim Six-Month Data from the Dose Escalation Cohorts of its Ongoing CNGB3 and CNGA3 Phase 1/2 Clinical Trials - Yahoo Finance
finance.yahoo.com - January 22 at 5:09 PM
Otonomy (OTIC) Provides Corporate and Product Pipeline Update - StreetInsider.comOtonomy (OTIC) Provides Corporate and Product Pipeline Update - StreetInsider.com
www.streetinsider.com - January 9 at 10:16 PM
Form 8-K OTONOMY, INC. For: Jan 09 - StreetInsider.comForm 8-K OTONOMY, INC. For: Jan 09 - StreetInsider.com
www.streetinsider.com - January 9 at 10:16 PM
Otonomy updates on product pipeline - Seeking AlphaOtonomy updates on product pipeline - Seeking Alpha
seekingalpha.com - January 9 at 5:15 PM
Otonomy Provides Corporate and Product Pipeline UpdateOtonomy Provides Corporate and Product Pipeline Update
finance.yahoo.com - January 9 at 5:15 PM
Should You Worry About Otonomy, Inc.'s (NASDAQ:OTIC) CEO Salary Level?Should You Worry About Otonomy, Inc.'s (NASDAQ:OTIC) CEO Salary Level?
finance.yahoo.com - January 7 at 3:41 PM
Global Ear Infection Treatment Market 2019-2023 | Evolving Opportunities with GlaxoSmithKline and Johnson & Johnson | Technavio - Yahoo FinanceGlobal Ear Infection Treatment Market 2019-2023 | Evolving Opportunities with GlaxoSmithKline and Johnson & Johnson | Technavio - Yahoo Finance
finance.yahoo.com - January 6 at 5:07 PM
Will Otonomy Continue to Surge Higher? - NasdaqWill Otonomy Continue to Surge Higher? - Nasdaq
www.nasdaq.com - January 2 at 9:11 PM
The Daily Biotech Pulse: Canadian Approval For Amarins Vascepa, Innate Pharmas Blood Cancer Drug Accepted For Review In Europe - Yahoo FinanceThe Daily Biotech Pulse: Canadian Approval For Amarin's Vascepa, Innate Pharma's Blood Cancer Drug Accepted For Review In Europe - Yahoo Finance
finance.yahoo.com - January 2 at 4:10 PM
Will Otonomy Continue to Surge Higher? - Yahoo FinanceWill Otonomy Continue to Surge Higher? - Yahoo Finance
finance.yahoo.com - January 2 at 4:10 PM
Benzingas Top Upgrades, Downgrades For December 24, 2019 - BenzingaBenzinga's Top Upgrades, Downgrades For December 24, 2019 - Benzinga
www.benzinga.com - December 26 at 11:58 PM
33 Stocks Moving In Tuesdays Mid-Day Session - Benzinga33 Stocks Moving In Tuesday's Mid-Day Session - Benzinga
www.benzinga.com - December 24 at 5:15 PM
The Daily Biotech Pulse: NewLink Genetics Licenses Ovarian Cancer Dug, Correvio Awaits FDA Verdict - Yahoo FinanceThe Daily Biotech Pulse: NewLink Genetics Licenses Ovarian Cancer Dug, Correvio Awaits FDA Verdict - Yahoo Finance
finance.yahoo.com - December 24 at 12:15 PM
Oppenheimer Starts Otonomy (OTIC) at Outperform - StreetInsider.comOppenheimer Starts Otonomy (OTIC) at Outperform - StreetInsider.com
www.streetinsider.com - December 24 at 7:14 AM
Otonomy +5% on new bullish start - Seeking AlphaOtonomy +5% on new bullish start - Seeking Alpha
seekingalpha.com - December 23 at 7:16 PM
Otonomy Inc (OTIC): Are Hedge Funds Right About This Stock? - Yahoo FinanceOtonomy Inc (OTIC): Are Hedge Funds Right About This Stock? - Yahoo Finance
finance.yahoo.com - December 16 at 12:37 PM
Otonomy Inc (OTIC): Are Hedge Funds Right About This Stock?Otonomy Inc (OTIC): Are Hedge Funds Right About This Stock?
finance.yahoo.com - December 16 at 7:37 AM
Top Ranked Momentum Stocks to Buy for December 3rdTop Ranked Momentum Stocks to Buy for December 3rd
finance.yahoo.com - December 13 at 11:45 PM
Top Ranked Momentum Stocks to Buy for December 3rd - Yahoo FinanceTop Ranked Momentum Stocks to Buy for December 3rd - Yahoo Finance
finance.yahoo.com - December 3 at 11:52 PM
Tinnitus Pipeline Review, H2 2019 - Analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type - ResearchAndMarkets.com - Business WireTinnitus Pipeline Review, H2 2019 - Analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type - ResearchAndMarkets.com - Business Wire
www.businesswire.com - December 3 at 6:52 PM
Otonomy to Participate in Two Upcoming Investor Conferences - Yahoo FinanceOtonomy to Participate in Two Upcoming Investor Conferences - Yahoo Finance
finance.yahoo.com - November 26 at 9:07 PM
AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2019 - GlobeNewswireAGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2019 - GlobeNewswire
www.globenewswire.com - November 12 at 7:41 PM
Edited Transcript of OTIC earnings conference call or presentation 5-Nov-19 9:30pm GMT - Yahoo FinanceEdited Transcript of OTIC earnings conference call or presentation 5-Nov-19 9:30pm GMT - Yahoo Finance
finance.yahoo.com - November 9 at 6:57 PM
Edited Transcript of OTIC earnings conference call or presentation 5-Nov-19 9:30pm GMTEdited Transcript of OTIC earnings conference call or presentation 5-Nov-19 9:30pm GMT
finance.yahoo.com - November 9 at 6:57 PM
Otonomy EPS beats by $0.12, misses on revenueOtonomy EPS beats by $0.12, misses on revenue
seekingalpha.com - November 7 at 7:59 AM
Otonomy (OTIC) Reports Q3 Loss, Lags Revenue Estimates - Yahoo FinanceOtonomy (OTIC) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
finance.yahoo.com - November 7 at 12:39 AM
Otonomy (OTIC) Reports Q3 Loss, Lags Revenue Estimates - NasdaqOtonomy (OTIC) Reports Q3 Loss, Lags Revenue Estimates - Nasdaq
www.nasdaq.com - November 5 at 10:41 PM
Otonomy (OTIC) Reports Q3 Loss, Lags Revenue EstimatesOtonomy (OTIC) Reports Q3 Loss, Lags Revenue Estimates
finance.yahoo.com - November 5 at 10:41 PM
Otonomy Reports Third Quarter 2019 Financial Results and Provides Corporate Update - Yahoo FinanceOtonomy Reports Third Quarter 2019 Financial Results and Provides Corporate Update - Yahoo Finance
finance.yahoo.com - November 5 at 5:40 PM
This page was last updated on 2/25/2020 by MarketBeat.com Staff

Featured Article: What is a Buy-Side Analyst?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel